Proacta S.A. develops and provides IT solutions. The company specializes in artificial intelligence, bioinformatics, and advanced medical and genetic data analysis. It offers Dbam o siebie Smart LAB, a platform that generates personalized reports based on laboratory test results; DBCU, an innovative platform using advanced technologies to optimize the breast cancer treatment process; and Patient Portal, an innovative tool for monitoring health, managing medical data, and supporting the treatment process. The company also provides AI/ML services and precise predictive models and software solutions. The company was formerly known as Codeaddict S.A. and changed its name to Proacta S.A. in July 2023. Proacta S.A. was incorporated in 2015 and is based in Warsaw, Poland.
Metrics to compare | PAC3 | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipPAC3PeersSector | |
|---|---|---|---|---|
P/E Ratio | −32.0x | 5.7x | 12.3x | |
PEG Ratio | - | 0.01 | 0.01 | |
Price/Book | 3.4x | 1.5x | 2.4x | |
Price / LTM Sales | 24.4x | 1.0x | 2.4x | |
Upside (Analyst Target) | - | −12.1% | 20.5% | |
Fair Value Upside | Unlock | 16.2% | 4.0% | Unlock |